BLFS · As filed with the SEC

Biolife Solutions balance sheet, by quarter

The statement as Biolife Solutions presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Unaudited Condensed Consolidated Balance Sheets · USD thousands

USD thousandsQ2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025
Q1 2025
Mar 31, 2025
Q4 2024
Dec 31, 2024
Q3 2024
Sep 30, 2024
Assets
Current assets:
Cash and cash equivalents23,99722,82233,03829,48131,90266,94595,38623,977
Restricted cash———————184
Available-for-sale securities, current portion58,41958,17455,88949,47349,86421,6359,19810,211
Accounts receivable, trade, net of allowance for credit losses of $16 and $22 as of June 30, 2026 and December 31, 2025, respectively10,65213,0577,95310,84210,0609,1679,16817,918
Inventories35,59132,83430,15527,82527,69027,56629,01332,179
Prepaid expenses and other current assets6,5396,3359,5268,9455,9165,8165,9964,914
Current assets, discontinued operations——0———00
Total current assets135,198133,222136,561126,566125,432131,129148,76189,383
Assets held for rent, net———5,1645,3075,6906,10310,822
Property and equipment, net15,23514,50414,71311,1017,6656,6056,08417,709
Operating lease right-of-use assets, net8,6447,1137,4667,6339,53410,12810,67414,402
Financing lease right-of-use assets, net———————30
Long-term deposits and other assets————378378379271
Other assets3,2893,0493,0502,419————
Available-for-sale securities, long-term30,65430,49931,25019,44418,47119,0554,6284,884
Equity investments———————995
Equity investments——000995995—
Intangible assets, net3,6543,9324,2577,4508,1498,8579,55918,415
Deferred tax assets, net42,233———————
Goodwill208,587208,587208,587212,304212,304212,304212,304224,741
Long-term assets, discontinued operations——0———00
Total assets447,494400,906405,884392,081387,240395,141399,487381,652
Liabilities and Shareholders’ Equity
Current liabilities:
Accounts payable2,4823,7501,4862,8903,2093,2973,5733,838
Accrued expenses and other current liabilities6,7987,57511,97410,9059,3118,21312,4518,449
Sales taxes payable2,0742,1132,2793,6813,5753,9294,2564,351
Warranty liability———————186
Lease liabilities, operating, current portion2,5932,3162,2432,1782,1661,8351,5112,788
Lease liabilities, financing, current portion———————323
Debt, current portion02,4994,9977,49210,05110,44910,94312,231
Current liabilities, discontinued operations——0———00
Total current liabilities13,94718,25322,97927,14628,31227,72332,73432,166
Lease liabilities, operating, long-term13,14510,04210,65711,00711,59812,16512,72315,189
Lease liabilities, financing, long-term———————913
Debt, long-term——0002,4994,9977,823
Deferred tax liabilities0198189189175130124100
Other long-term liabilities399183171—————
Long-term liabilities, discontinued operations——0———00
Total liabilities27,49128,67633,99638,34240,08542,51750,57856,191
Shareholders’ equity:
Preferred stock, $0.001 par value; 1,000,000 shares authorized, Series A, 4,250 shares designated, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 202500000000
Common stock, $0.001 par value; 150,000,000 shares authorized, 48,889,090 and 48,198,928 shares issued and outstanding, respectively, as of June 30, 2026 and December 31, 20254949484848484746
Additional paid-in capital713,571710,811711,404704,327698,423688,092683,939673,183
Accumulated other comprehensive (loss) income, net of tax(211)(120)132130713324(208)
Accumulated deficit(293,406)(338,510)(339,696)(350,766)(351,387)(335,549)(335,101)(347,560)
Total shareholders’ equity420,003372,230371,888353,739347,155352,624348,909325,461
Total liabilities and shareholders’ equity447,494400,906405,884392,081387,240395,141399,487381,652

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.